Bill Gates-Backed Companies Approved To Sell ‘Lab-Grown’ Chicken in the US

The U.S. Department of Agriculture gave the green light for the controversial product, which is backed by Bill Gates, earlier this week.

The United States has become the second country in the world to approve “cell-based” chicken for public consumption, joining Singapore, who legalized the experimental food in 2020. The U.S. Department of Agriculture gave the green light for the controversial product, which is backed by Bill Gates, earlier this week.

Billed as a major tool in the fight against “climate change,” so-called “cultivated chicken” is grown in a lab. The costly process involves extracting stem cells and giving them a nutrient-dense bath in vitamins, minerals, salt, and even soy inside a steel bioreactor. An average batch takes about two weeks to harvest. 

Proponents argue that the controlled, indoor environment ensures sanitation standards are more easily metand that the alleged harmful effects of raising animals on a farm are avoided entirely. Critics question not only its moral aspects but its purported nutritional benefits as well.

“I’d rather eat my shoe than lab-grown meat,” dietitian Diana Rodgers told The New York Post Wednesday. TV personality chef Andrew Gruel called it “a junk product” filled with “additives.” 

On average, Americans eat 8 billion chickens per yearAt present, two California-based companies create lab-grown poultry — Upside Foods and Good Meat, a division of Eat Just Incorporated. Upside was founded in 2015 by a former Mayo Clinic cardiologist. 

According to multiple media outlets, Bill Gates is among the investors in both Upside Foods and East Just, which began selling synthetic eggs to retail stores in 2019. Gates has backed an array of other companies pushing genetically modified food as well, including Beyond Meat and Impossible Foods. 

Upside’s Chief Operating Officer Amy Chen spoke with Fox News host Neil Cavuto earlier this week about the USDA’s approval and the future of “cultivated food.” 

Read the Whole Article